Skip to content
Application 019661
- Type
- NDA
- Sponsor
- CHEPLAPHARM
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CYTOVENE | GANCICLOVIR SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0004-6940 | Cytovene | ganciclovir sodium | Genentech, Inc. | NDA | Current |
| 0004-6940 | Cytovene | ganciclovir sodium | Genentech, Inc. | NDA | Current |
| 61269-450 | Cytovene | ganciclovir sodium | H2-Pharma, LLC | NDA | Current |
| 61269-450 | Cytovene | ganciclovir sodium | H2-Pharma, LLC | NDA | Current |
| 61269-450 | Cytovene | ganciclovir sodium | H2-Pharma, LLC | NDA | Current |
| 61269-450 | Cytovene | ganciclovir sodium | H2-Pharma, LLC | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 69818 | SUPPL | 2022-01-06 |
| 63155 | SUPPL | 2020-05-20 |
| 55122 | SUPPL | 2018-08-07 |
| 48909 | SUPPL | 2017-07-05 |
| 48908 | SUPPL | 2017-07-05 |
| 17533 | SUPPL | 2006-02-02 |
| 11611 | SUPPL | 2006-02-02 |